Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation

Peter A. Noseworthy, Xiaoxi Yao, Nilay D. Shah, Bernard J. Gersh

Research output: Contribution to journal › Letter › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation'. Together they form a unique fingerprint.